Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice
- PMID: 3087441
Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice
Abstract
Normal adult C57BL, BALB/c, and C3H/HeJ mice were injected intraperitoneally three times daily for up to 6 days with 102,000 U (200 ng) per injection of purified, bacterially synthesized, Multipotential colony-stimulating factor (CSF) (Interleukin-3) (rMulti-CSF) and compared with control mice injected with serum/saline with or without added endotoxin (1 ng/mL). Mice injected with rMulti-CSF exhibited tenfold rises in blood eosinophil and twofold to threefold rises in neutrophil and monocyte levels. The spleens from mice injected with rMulti-CSF showed a 50% increase in weight, elevated levels of maturing granulocytes, eosinophils, nucleated erythroid cells and megakaryocytes, and up to 100-fold rises in mast cells. Progenitor cell frequencies in the spleen were elevated sixfold to 18-fold. No significant changes were observed in the marrow. Sixfold to 15-fold rises were observed in peritoneal cell populations of mice injected with rMulti-CSF with evidence of increased peritoneal macrophage phagocytic activity. Livers of C57BL mice, but not of the other strains, exhibited increased numbers of infiltrating hematopoietic cells whereas rises in mast cell numbers were observed in the mesenteric lymph node, skin, and gut in BALB/c and C3H/HeJ mice. Endotoxin was excluded as being responsible for the observed changes except possibly those involving peritoneal macrophage phagocytic activity. The results indicate that the injection of normal mice with rMulti-CSF significantly stimulates the same types of hematopoietic populations as are stimulated in vitro by Multi-CSF and indicate that this and other CSFs should be useful in stimulating hematopoietic repopulation and functional activity in vivo.
Similar articles
-
Quantitative responsiveness of murine hemopoietic populations in vitro and in vivo to recombinant multi-CSF (IL-3).Exp Hematol. 1987 Mar;15(3):288-95. Exp Hematol. 1987. PMID: 3493174
-
Hemopoietic responses in mice injected with purified recombinant murine GM-CSF.Exp Hematol. 1987 Jan;15(1):1-9. Exp Hematol. 1987. PMID: 3490993
-
Hemopoietic effects of purified bacterially synthesized multi-CSF in normal and marrow-transplanted mice.Immunobiology. 1986 Sep;172(3-5):158-67. doi: 10.1016/S0171-2985(86)80095-X. Immunobiology. 1986. PMID: 3542809
-
Stimulation of hematopoiesis in vivo by recombinant bacterial murine interleukin 3.Proc Natl Acad Sci U S A. 1986 Feb;83(4):1001-5. doi: 10.1073/pnas.83.4.1001. Proc Natl Acad Sci U S A. 1986. PMID: 3081887 Free PMC article.
-
[Interleukin 3 (IL-3)].Gan To Kagaku Ryoho. 1994 May;21(6):915-25. Gan To Kagaku Ryoho. 1994. PMID: 8185355 Review. Japanese.
Cited by
-
Retrovirus-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells result in a myeloproliferative disorder.Mol Cell Biol. 1989 Feb;9(2):798-808. doi: 10.1128/mcb.9.2.798-808.1989. Mol Cell Biol. 1989. PMID: 2565534 Free PMC article.
-
Colony-stimulating factors in the pathogenesis and treatment of disease.Postgrad Med J. 1987 Dec;63(746):1061-8. doi: 10.1136/pgmj.63.746.1061. Postgrad Med J. 1987. PMID: 3330237 Free PMC article. Review. No abstract available.
-
The tolerability of continuous intravenous infusion of interleukin-3 after DHAP chemotherapy in patients with relapsed malignant lymphoma. A phase-I study.Ann Hematol. 1993 Oct;67(4):175-81. doi: 10.1007/BF01695864. Ann Hematol. 1993. PMID: 8218538 Clinical Trial.
-
Acceleration of IgE responses by treatment with recombinant interleukin-3 prior to infection with Trichinella spiralis in mice.Immunology. 1996 Apr;87(4):642-6. doi: 10.1046/j.1365-2567.1996.505586.x. Immunology. 1996. PMID: 8675221 Free PMC article.
-
Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts.Vet Pathol. 2021 Jan;58(1):181-204. doi: 10.1177/0300985820970144. Epub 2020 Nov 19. Vet Pathol. 2021. PMID: 33208054 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources